Bharat Rasayan Ltd

₹ 11,362 0.04%
28 Jun - close price
About

Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.[1]

Key Points

Product Portfolio
The company manufactures a wide range of pesticides including insecticides, fungicides, herbicides, weedicides, intermediates and plant growth regulators. It caters to all the pest problems of major crops grown in India including paddy, cotton, soybean, sugarcane and other crops. [1]
It has a portfolio of over 200+ different products registered with the Central Insecticides Board and have ~100 brands.[2]

  • Market Cap 4,721 Cr.
  • Current Price 11,362
  • High / Low 15,132 / 9,438
  • Stock P/E 26.2
  • Book Value 1,857
  • Dividend Yield 0.01 %
  • ROCE 28.4 %
  • ROE 24.0 %
  • Face Value 10.0

Pros

  • Company is expected to give good quarter
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.86%
  • Company's median sales growth is 22.59% of last 10 years

Cons

  • Debtor days have increased from 101.46 to 130.08 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
354 366 224 271 282 318 222 270 252 269 335 445
284 299 181 223 216 261 171 204 194 229 265 358
Operating Profit 71 67 43 48 65 58 51 66 58 40 70 87
OPM % 20% 18% 19% 18% 23% 18% 23% 24% 23% 15% 21% 19%
1 3 2 8 4 -2 0 3 3 3 -0 6
Interest 5 4 4 3 2 1 -1 2 1 1 2 3
Depreciation 4 4 7 7 6 7 7 7 6 6 7 7
Profit before tax 63 61 35 46 61 48 45 61 54 36 61 83
Tax % 34% 11% 28% 22% 24% 27% 22% 22% 26% 26% 25% 23%
Net Profit 42 55 25 36 47 35 35 47 40 27 46 65
EPS in Rs 98.22 128.56 59.01 85.25 109.92 83.13 82.92 111.14 95.85 64.69 110.41 155.32

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
94 142 185 360 438 451 618 792 989 1,213 1,091 1,301
90 125 159 296 355 370 508 634 802 983 851 1,046
Operating Profit 3 17 26 64 82 81 111 159 188 230 240 255
OPM % 4% 12% 14% 18% 19% 18% 18% 20% 19% 19% 22% 20%
7 -0 0 1 1 1 2 4 1 14 6 12
Interest 0 1 5 17 18 13 12 12 16 16 4 7
Depreciation 2 2 7 18 18 17 16 16 17 22 26 25
Profit before tax 8 14 14 30 48 52 84 135 155 205 216 235
Tax % 27% 28% 32% 33% 34% 34% 35% 27% 28% 23% 24% 25%
Net Profit 6 10 10 20 32 34 55 98 112 158 164 177
EPS in Rs 13.86 23.14 22.57 47.43 74.73 79.74 128.35 231.39 262.48 371.03 387.11 426.27
Dividend Payout % 9% 5% 0% 2% 2% 2% 1% 1% 1% 0% 0% 0%
Compounded Sales Growth
10 Years: 25%
5 Years: 16%
3 Years: 10%
TTM: 19%
Compounded Profit Growth
10 Years: 33%
5 Years: 27%
3 Years: 17%
TTM: 9%
Stock Price CAGR
10 Years: 56%
5 Years: 31%
3 Years: 41%
1 Year: -10%
Return on Equity
10 Years: 29%
5 Years: 29%
3 Years: 27%
Last Year: 24%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
4 4 4 4 4 4 4 4 4 4 4 4
Reserves 39 49 58 78 109 142 196 294 405 560 724 768
8 39 131 143 140 111 115 128 247 94 58 174
13 34 53 82 82 69 54 77 100 94 122 146
Total Liabilities 65 126 246 307 335 326 369 504 756 752 908 1,092
20 16 135 142 137 136 131 148 150 203 191 228
CWIP 3 48 0 1 2 1 1 7 35 18 18 11
Investments 1 1 0 0 30 20 0 0 0 9 151 45
41 60 111 164 167 169 237 349 570 522 549 807
Total Assets 65 126 246 307 335 326 369 504 756 752 908 1,092

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
10 13 -8 29 60 47 16 29 -52 263 170 -65
-7 -42 -77 -25 -41 -5 8 -31 -46 -53 -149 51
-5 30 87 -3 -19 -43 -24 2 102 -169 -40 -25
Net Cash Flow -2 1 3 1 -0 -1 -0 0 4 40 -19 -39

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 62 77 89 61 66 71 71 102 103 75 99 130
Inventory Days 68 65 108 105 73 71 75 66 112 70 90 120
Days Payable 41 31 56 58 48 32 17 25 24 17 33 30
Cash Conversion Cycle 89 111 141 108 91 110 129 143 191 128 156 221
Working Capital Days 109 68 117 86 75 86 110 127 173 116 134 185
ROCE % 10% 21% 14% 22% 27% 25% 34% 39% 32% 34% 31% 28%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents